|

Blood sampling Clinical Trials

17 actively recruiting trials

Also known as: Tumor sampling

Pipeline

Early 1: 1

Top Sponsors

University Hospital, Toulouse3
Hospices Civils de Lyon3
Centre Hospitalier Universitaire Dijon3
Assistance Publique - Hôpitaux de Paris2
University Hospital, Clermont-Ferrand1

Indications

Cancer10
Spondyloarthritis2
Lupus2
Arthritis2
Rheumatoid Arthritis2

Other17 trials

Analysis of Circulating Tumor Markers in Blood

N/A

B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.

Early 1

Biobank for Inflammatory Chronic Diseases and Osteoporosis

Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.

N/A

Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis

Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer

N/A

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls

N/A

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

N/A

Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms

N/A

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

N/A

Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study

N/A

Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma

N/A

Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer

The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).

cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.